MX345888B - Emulsion aceite en agua de mometasona y propilenglicol. - Google Patents
Emulsion aceite en agua de mometasona y propilenglicol.Info
- Publication number
- MX345888B MX345888B MX2011011959A MX2011011959A MX345888B MX 345888 B MX345888 B MX 345888B MX 2011011959 A MX2011011959 A MX 2011011959A MX 2011011959 A MX2011011959 A MX 2011011959A MX 345888 B MX345888 B MX 345888B
- Authority
- MX
- Mexico
- Prior art keywords
- oil
- mometasone
- propylene glycol
- water emulsion
- water
- Prior art date
Links
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 title abstract 9
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 title abstract 3
- 229960001664 mometasone Drugs 0.000 title abstract 3
- 239000007764 o/w emulsion Substances 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 239000006071 cream Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200900601 | 2009-05-12 | ||
| PCT/EP2010/002921 WO2010130428A1 (en) | 2009-05-12 | 2010-05-12 | Oil-in-water emulsion of mometasone and propylene glycol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2011011959A MX2011011959A (es) | 2012-05-08 |
| MX345888B true MX345888B (es) | 2017-02-22 |
Family
ID=42352732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2011011959A MX345888B (es) | 2009-05-12 | 2010-05-12 | Emulsion aceite en agua de mometasona y propilenglicol. |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US8728497B2 (https=) |
| EP (2) | EP2429510B1 (https=) |
| JP (2) | JP5833541B2 (https=) |
| CN (1) | CN102458382B (https=) |
| AU (1) | AU2010246613B2 (https=) |
| BR (1) | BRPI1010907B8 (https=) |
| CA (1) | CA2761739C (https=) |
| CY (1) | CY1116667T1 (https=) |
| DK (1) | DK2429510T3 (https=) |
| ES (2) | ES2547556T3 (https=) |
| HR (1) | HRP20150959T1 (https=) |
| HU (1) | HUE027718T2 (https=) |
| MX (1) | MX345888B (https=) |
| NZ (1) | NZ596429A (https=) |
| PL (2) | PL2429510T3 (https=) |
| PT (1) | PT2429510E (https=) |
| RU (1) | RU2526911C2 (https=) |
| SI (1) | SI2429510T1 (https=) |
| SM (1) | SMT201500297B (https=) |
| WO (1) | WO2010130428A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2547556T3 (es) | 2009-05-12 | 2015-10-07 | Galenica Ab | Emulsión de aceite en agua de mometasona y propilenglicol |
| PT105982B (pt) * | 2011-11-03 | 2014-07-29 | Laboratório Edol Produtos Farmac Uticos S A | Composição e método de preparação a frio de uma emulsão utilizada como veículo de fármacos anti-inflamatórios |
| JP7262227B2 (ja) * | 2017-10-23 | 2023-04-21 | マルホ株式会社 | 被膜形成外用剤 |
| US20190282465A1 (en) * | 2018-03-19 | 2019-09-19 | Essential Lipid Technologies, LLC | Topical Phospholipid Formulations and Methods for Preparing the Same |
| JP2026501094A (ja) | 2022-12-20 | 2026-01-14 | ガレニカ デルマ エービー | 局所的皮膚処置のための新規な組成物 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4282216A (en) * | 1977-04-20 | 1981-08-04 | Johnson & Johnson | Topical anti-inflammatory drug therapy |
| US4808610A (en) | 1986-10-02 | 1989-02-28 | Schering Corporation | Mometasone furoate anti-inflammatory cream composition using hexylene glycol |
| WO1991008733A1 (en) * | 1989-12-20 | 1991-06-27 | Schering Corporation | Stable cream and lotion bases for lipophilic drug compositions |
| US6127353A (en) | 1991-09-06 | 2000-10-03 | Schering Corporation | Mometasone furoate monohydrate, process for making same and pharmaceutical compositions |
| WO1994013257A1 (en) * | 1992-12-16 | 1994-06-23 | Creative Products Resource Associates, Ltd. | Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder |
| US5696105A (en) * | 1996-03-14 | 1997-12-09 | Hackler; Walter A. | Antifungal nail composition |
| US5952003A (en) * | 1996-08-01 | 1999-09-14 | Novartis Corporation | Terazosin capsules |
| US6075056A (en) | 1997-10-03 | 2000-06-13 | Penederm, Inc. | Antifungal/steroid topical compositions |
| US6720001B2 (en) * | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
| US7030203B2 (en) * | 2001-09-28 | 2006-04-18 | 3M Innovative Properties Company | Water-in-oil emulsions with ethylene oxide groups, compositions, and methods |
| PE20030828A1 (es) * | 2002-03-04 | 2003-11-04 | Novartis Ag | Composicion oftalmica que comprende ascomicina |
| TR200201343A2 (tr) * | 2002-05-17 | 2003-12-22 | Orva İlaç Sanayi̇ Ve Ti̇caret A. Ş. | Kortikosteroid ve antiseptik içeren farmasötik bileşim |
| DK1542904T3 (da) | 2002-08-27 | 2008-04-21 | Schering Corp | Fremgangsmåde til fremstilling af formuleringer til en inhalator med målte doser |
| US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US20060104968A1 (en) * | 2003-03-05 | 2006-05-18 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases |
| US7312207B2 (en) * | 2003-05-23 | 2007-12-25 | Taro Pharmaceuticals North America, Inc. | Topical steroid cream formulations |
| EP1631290A2 (en) | 2003-05-23 | 2006-03-08 | Combinatorx, Incorporated | Combination therapy for the treatment of neoplasms |
| US20050196462A1 (en) * | 2003-12-30 | 2005-09-08 | Oculus Innovative Sciences, Inc. | Topical formulation containing oxidative reductive potential water solution and method for using same |
| US20070099883A1 (en) * | 2005-10-07 | 2007-05-03 | Cheryl Lynn Calis | Anhydrous mometasone furoate formulation |
| DE102006034883A1 (de) * | 2006-07-25 | 2008-01-31 | Hermal Kurt Herrmann Gmbh & Co. Ohg | Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat |
| EP2120868A4 (en) | 2007-04-11 | 2010-08-25 | Perrigo Israel Phamaceuticals | LOW-DOSED MOMETASON FORMULATIONS |
| ES2547556T3 (es) | 2009-05-12 | 2015-10-07 | Galenica Ab | Emulsión de aceite en agua de mometasona y propilenglicol |
| PT2429490T (pt) | 2009-05-12 | 2017-02-08 | Galenica Ab | Emulsão de óleo em água de mometasona |
-
2010
- 2010-05-12 ES ES10721697.0T patent/ES2547556T3/es active Active
- 2010-05-12 DK DK10721697.0T patent/DK2429510T3/en active
- 2010-05-12 US US13/319,758 patent/US8728497B2/en active Active
- 2010-05-12 AU AU2010246613A patent/AU2010246613B2/en active Active
- 2010-05-12 MX MX2011011959A patent/MX345888B/es active IP Right Grant
- 2010-05-12 HU HUE10721697A patent/HUE027718T2/en unknown
- 2010-05-12 PL PL10721697T patent/PL2429510T3/pl unknown
- 2010-05-12 EP EP10721697.0A patent/EP2429510B1/en active Active
- 2010-05-12 ES ES15172934T patent/ES2813400T3/es active Active
- 2010-05-12 WO PCT/EP2010/002921 patent/WO2010130428A1/en not_active Ceased
- 2010-05-12 HR HRP20150959TT patent/HRP20150959T1/hr unknown
- 2010-05-12 PT PT107216970T patent/PT2429510E/pt unknown
- 2010-05-12 NZ NZ596429A patent/NZ596429A/xx not_active IP Right Cessation
- 2010-05-12 CA CA2761739A patent/CA2761739C/en active Active
- 2010-05-12 EP EP15172934.0A patent/EP2962688B1/en active Active
- 2010-05-12 CN CN201080030169.1A patent/CN102458382B/zh active Active
- 2010-05-12 JP JP2012510162A patent/JP5833541B2/ja active Active
- 2010-05-12 PL PL15172934T patent/PL2962688T3/pl unknown
- 2010-05-12 SI SI201031007T patent/SI2429510T1/sl unknown
- 2010-05-12 RU RU2011150246/15A patent/RU2526911C2/ru active
- 2010-05-12 BR BRPI1010907A patent/BRPI1010907B8/pt active IP Right Grant
-
2014
- 2014-02-24 US US14/187,997 patent/US11395827B2/en active Active
-
2015
- 2015-07-16 JP JP2015142118A patent/JP2015227354A/ja active Pending
- 2015-09-03 CY CY20151100770T patent/CY1116667T1/el unknown
- 2015-11-30 SM SM201500297T patent/SMT201500297B/it unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4403579A3 (en) | Formulation for anti-alpha4beta7 antibody | |
| MX2021006035A (es) | Formulaciones cannabinoides estables. | |
| WO2012079092A3 (en) | Testosterone undecanoate compositions | |
| MX382192B (es) | Composiciones de canabinoide y usos. | |
| WO2012075081A3 (en) | High-strength testosterone undecanoate compositions | |
| WO2012098562A3 (en) | Liquid oral compositions of lanthanum salts | |
| EP2579851A4 (en) | SOFTMAKER AEROSOL FOAM COMPOSITIONS OF HIGH OIL CONTENT | |
| BR112013022495A2 (pt) | formulação farmacêutica aquosa de tapentadol para administração oral | |
| WO2012035480A3 (en) | Pharmaceutical compositions of curcumin | |
| MX2010002392A (es) | Composiciones de brimonidina mejoradas para tratar eritema. | |
| EA201291108A1 (ru) | Фармацевтические композиции в виде эмульсии с низким содержанием масла, содержащие прогестоген | |
| WO2012154679A8 (en) | Tricyclic pyrazole sulfonamide compounds and methods of making and using same | |
| IN2014KN01075A (https=) | ||
| MX2009007784A (es) | Composiciones de tiacumicinas estables. | |
| MX2013001677A (es) | Formulaciones estables de linaclotida. | |
| WO2013183062A3 (en) | Palatable formulations of ibuprofen | |
| EA201300539A1 (ru) | Твердая композиция для приема внутрь (варианты), способ терапевтической или нетерапевтической профилактики желудочно-кишечных расстройств или поддержания здорового состояния желудочно-кишечного тракта с ее помощью (варианты) и упаковка, ее содержащая | |
| PH12012502085A1 (en) | Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same | |
| WO2015033302A3 (en) | Fulvestrant compositions | |
| MX345888B (es) | Emulsion aceite en agua de mometasona y propilenglicol. | |
| HK1222337A1 (zh) | 用於施加药物活性成分或化妆品活性成分的局部组合物和载体 | |
| EA201490363A1 (ru) | Новые составы на основе (триметоксифениламино)пиримидинилов | |
| UA75461U (uk) | Засіб для профілактики стоматологічних захворювань | |
| MY160377A (en) | Topical pharmaceutical compositions | |
| BR112015001627A2 (pt) | composição farmacêutica, respectivos usos e método para diminuir a frequência de micção |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |